BlackRock Fund Advisors - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 24 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$306,000
-8.9%
19,623
-23.8%
0.00%
Q3 2016$336,000
+189.7%
25,739
+52.5%
0.00%
Q2 2016$116,000
-86.4%
16,878
-81.3%
0.00%
Q1 2016$851,000
-11.3%
90,105
-5.4%
0.00%
Q4 2015$959,000
-18.7%
95,220
+15.4%
0.00%
Q3 2015$1,180,00082,4780.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 2,679,457$20,257,0000.73%
Portolan Capital Management 777,293$5,876,0000.66%
CAMPBELL CAPITAL MANAGEMENT INC 110,451$835,0000.62%
ZEKE CAPITAL ADVISORS, LLC 402,212$3,041,0000.27%
Leap Investments LP 46,084$348,0000.17%
Bernardo Wealth Planning LLC 26,419$199,0000.14%
Claraphi Advisory Network, LLC 14,744$111,0000.07%
Sterling Investment Advisors, Ltd. 11,000$83,0000.04%
A.R.T. Advisors, LLC 81,372$615,0000.03%
Mirae Asset Global Investments Co., Ltd. 544,408$4,116,0000.03%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders